The Short Report | Curated Financial Analysis from Top Experts
Hero Background

Cut through the noise.
Trade on the signal.

A weekly synthesis of institutional-grade financial reports and market mechanics.

No spam. Unsubscribe anytime.

All Reports

Filters

Companies

Tickers

Authors

Latest Reports

RR Richtech Robotics

BREAKING: Microsoft Denies Partnership with Richtech Robotics

Richtech Robotics stock manipulation exposed: Microsoft partnership claims contradicted, 40% surge followed by $38.7M private placement, $5M revenue vs $16M losses, missed SEC filings, prior fraud allegations. Pump-and-dump scheme analysis

Jan 29, 2026 8 min read
SIDU Fugazi Research

The Black Hole at $SIDU: Where Massive Amounts of Capital Get Sucked Into the Void

SIDU Space short thesis: related-party revenue dominance (47-50%), massive shareholder dilution (64M+ shares), $2M monthly cash burn, negative unit economics, CEO conflicts of interest, no profitability path, government contracts symbolic only, $500M shelf registration risk

Jan 26, 2026 11 min read

Botswana’s Bad Batch

Defective TB drugs lacking active ingredients caused treatment failures to nearly double in Botswana after emergency procurement bypassed quality controls, sourcing from an unproven India-based supplier — part of a systemic global supply chain collapse affecting South Africa, the UK, and Australia

Jan 26, 2026 7 min read
FICO UBER

Bristlemoon December 2025 Quarterly Letter

Bristlemoon Global Fund Q4 2025 quarterly update: -6.2% return, 11.9% 18-month cumulative performance. Long positions in Adobe, Floor & Decor, Baltic Classifieds. Short profits from Nike, Starbucks, National Vision Holdings. Active long/short hedge fund strategy analysis

Jan 9, 2026 4 min read

“Bullshit” The New Way Health Giants Hide Billions

CVS, UnitedHealth, and Cigna allegedly created shell GPO subsidiaries retaining 15–20% of drug rebates as hidden fees despite "100% pass-through" promises, operating from ghost offices yet generating ~$50M revenue per employee — drawing federal investigations and multi-million dollar settlements

Jan 7, 2026 9 min read
LAES SealSQ

SEAL SQ & SEALCOIN: A Legitimate Vision or a Fundraising Ploy?

SealSQ LAES stock bearish research: cryptocurrency SEALCOIN lacks technical details, company rebrands off-shelf chips without manufacturing, 59% stock decline since 2023 spin-off. Concerns about legitimacy, unfocused strategy, potential fundraising scheme with WISeKey tokenization

Jan 6, 2026 5 min read
QUBT Quantum Computing Inc.

BMF Reports

BMF Reports bearish analysis of QUBT stock reveals toxic financing, 39% shareholder dilution, $311K revenue vs $17M losses, idle Tempe foundry, non-binding partnerships, and serial pivots from Ticketcart to quantum computing. Critical bearish equity research on Quantum Computing Inc.

Jan 6, 2026 7 min read
Herb Greenberg Ed Borgato

Replay – You’re Not as Dumb as You Feel

Ed Borgato investment wisdom: humility, emotional discipline, and behavioral patterns from Lehman Brothers veteran. Market psychology, avoiding predictions, patience as competitive advantage, and timeless investing principles for navigating stock market cycles successfully

Jan 2, 2026 6 min read
ACHV Achieve Life Sciences

“Put it in the water!” - How a Toxic Tree May Save Thousands of Smokers

Achieve Life Sciences ACHV stock analysis: cytisinicline smoking cessation breakthrough therapy with Phase 3 trial success offset by financial runway crisis, supply chain risks, and promotional stock activity. Independent equity research with disclosed long position by Hunterbrook Capital

Dec 30, 2025 7 min read

Antibodies, Antibody Fragments, and Peptides: Targeting Muscular Diseases with RNA

RNA therapeutics targeting muscular diseases face unresolved delivery and nuclear access challenges that companies may be understating, with PepGen's 53.7% splicing correction dwarfing Avidity's 16% and Dyne's 27% — raising questions about measurement consistency or overstated claims

Dec 19, 2025 6 min read

Vedanta – ITD Alleges Tax Evasion by VRL

India's Income Tax Department alleges Vedanta used an offshore Mauritius entity to evade ~$145M in taxes, with potential 200% penalties, while six statutory demands and an adverse order were allegedly never disclosed to bondholders despite Vedanta's own disclosure policy

Dec 19, 2025 4 min read
NUTX Capybara Research

Problems at Nutex, Part Two: Misunderstood by Investors and Facing a Revenue Cliff As Schemes Unravel

Capybara Research exposes Nutex Health's alleged systematic billing fraud, revealing a 228% revenue spike, massive receivables inflation, and potential $300M markdown risk through fraudulent arbitration practices with HaloMD

Dec 16, 2025 9 min read

The Signal. No Noise.

Join 50,000+ investors receiving our weekly synthesis.